|
|
positive regulation of metanephric mesenchymal cell migration
|
GO:2000591 |
1 |
0.542
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.510
|
|
|
|
positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:0035793 |
1 |
0.434
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.427
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.375
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.374
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.366
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.350
|
|
|
|
cell migration involved in coronary angiogenesis
|
GO:0060981 |
1 |
0.303
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.298
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.280
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.276
|
|
|
|
regulation of vasculogenesis
|
GO:2001212 |
9 |
0.275
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.271
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.242
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.241
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.241
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.232
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.225
|
|
|
|
negative regulation of endothelial cell apoptotic process
|
GO:2000352 |
7 |
0.214
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.208
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.207
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.207
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.206
|
Mouse |
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.204
|
|
|
|
regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:1900238 |
1 |
0.201
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.199
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.186
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.183
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.181
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.177
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.174
|
|
|
|
response to erythropoietin
|
GO:0036017 |
1 |
0.173
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.173
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.170
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.168
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.166
|
|
|
|
erythropoietin mediated signaling pathway
|
GO:0038162 |
1 |
0.157
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.155
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.154
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.152
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.151
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.150
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.146
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.144
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.140
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.137
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.136
|
|
|
|
pro t cell differentiation
|
GO:0002572 |
3 |
0.134
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.133
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.132
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.128
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.126
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.125
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.123
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.121
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.119
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.119
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.117
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.116
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.115
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.114
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.112
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.112
|
|
|
|
smooth muscle cell chemotaxis
|
GO:0071670 |
2 |
0.110
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.110
|
|
|
|
positive regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014718 |
2 |
0.108
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.108
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.107
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.106
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.105
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.104
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.102
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.101
|
|
|
|
intrahepatic bile duct development
|
GO:0035622 |
2 |
0.101
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.101
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.100
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.098
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.098
|
|
|
|
detection of mechanical stimulus involved in equilibrioception
|
GO:0050973 |
2 |
0.097
|
|
|
|
cellular response to stem cell factor stimulus
|
GO:0036216 |
3 |
0.097
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.096
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.096
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.092
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.090
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.090
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.090
|
|
|
|
regulation of hippo signaling
|
GO:0035330 |
1 |
0.090
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.089
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.089
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.088
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.088
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.088
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.088
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.087
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.086
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.086
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.086
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.086
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.086
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.085
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.084
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.084
|
|
|
|
regulation of metanephric mesenchymal cell migration
|
GO:2000589 |
2 |
0.083
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.083
|
|
|
|
cardiac endothelial cell differentiation
|
GO:0003348 |
4 |
0.083
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.082
|
Mouse |
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.081
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.080
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.079
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.078
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.078
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.078
|
|
|
|
metanephric mesenchymal cell migration
|
GO:0035789 |
2 |
0.077
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.077
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.077
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.076
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.076
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.075
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.074
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.074
|
|
|
|
cellular response to erythropoietin
|
GO:0036018 |
1 |
0.074
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.074
|
|
|
|
regulation of transcription involved in primary germ layer cell fate commitment
|
GO:0060796 |
2 |
0.073
|
|
|
|
ureter urothelium development
|
GO:0072190 |
3 |
0.073
|
|
|
|
vascular endothelial growth factor receptor signaling pathway
|
GO:0048010 |
24 |
0.073
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.072
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.072
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.071
|
|
|
|
dendritic cell cytokine production
|
GO:0002371 |
3 |
0.070
|
|
|
|
epithelial cell proliferation involved in prostatic bud elongation
|
GO:0060517 |
1 |
0.070
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.069
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.069
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.068
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.068
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.068
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.068
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.067
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.067
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.067
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.067
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.067
|
|
|
|
ascending aorta development
|
GO:0035905 |
3 |
0.066
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.066
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.066
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
3 |
0.065
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.065
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.064
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.064
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.064
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.064
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.063
|
|
|
|
melanocyte migration
|
GO:0097324 |
2 |
0.063
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.063
|
|
|
|
negative regulation of b cell differentiation
|
GO:0045578 |
4 |
0.063
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.062
|
|
|
|
endocardial cell differentiation
|
GO:0060956 |
4 |
0.061
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.061
|
|
|
|
positive regulation of lens epithelial cell proliferation
|
GO:2001111 |
1 |
0.060
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.060
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.060
|
|
|
|
inner cell mass cellular morphogenesis
|
GO:0001828 |
1 |
0.060
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.059
|
|
|
|
detection of mechanical stimulus involved in sensory perception of sound
|
GO:0050910 |
16 |
0.059
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.058
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.058
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.057
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.056
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.055
|
|
|
|
male germ line sex determination
|
GO:0019100 |
2 |
0.055
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.055
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.054
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.054
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.054
|
|
|
|
striatal medium spiny neuron differentiation
|
GO:0021773 |
2 |
0.053
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.053
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.053
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.053
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.053
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.052
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.052
|
|
|
|
myeloid dendritic cell chemotaxis
|
GO:0002408 |
2 |
0.052
|
|
|
|
platelet derived growth factor receptor beta signaling pathway
|
GO:0035791 |
4 |
0.052
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.052
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.052
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.051
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.051
|
Mouse |
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.051
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.051
|
|
|
|
cell migration involved in vasculogenesis
|
GO:0035441 |
2 |
0.051
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.051
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.050
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.049
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.049
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.049
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.049
|
|
|
|
melanocyte adhesion
|
GO:0097326 |
1 |
0.048
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.048
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.047
|
|
|
|
positive regulation of rac protein signal transduction
|
GO:0035022 |
1 |
0.047
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.047
|
|
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
21 |
0.047
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.047
|
|
|
|
detection of mechanical stimulus involved in sensory perception
|
GO:0050974 |
23 |
0.047
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.047
|
|
|
|
regulation of endothelial cell apoptotic process
|
GO:2000351 |
9 |
0.046
|
|
|
|
regulation of vascular endothelial growth factor receptor signaling pathway
|
GO:0030947 |
14 |
0.046
|
|
|
|
cell migration involved in endocardial cushion formation
|
GO:0003273 |
3 |
0.046
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.046
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.046
|
|
|
|
cell migration involved in kidney development
|
GO:0035787 |
3 |
0.046
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.046
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.045
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.045
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.045
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.045
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.045
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.044
|
|
|
|
basement membrane assembly
|
GO:0070831 |
2 |
0.044
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.044
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.044
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.044
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.044
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.044
|
|
|
|
endocardium formation
|
GO:0060214 |
4 |
0.043
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.043
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.043
|
|
|
|
atrial septum primum morphogenesis
|
GO:0003289 |
3 |
0.043
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.043
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.043
|
|
|
|
regulation of blood vessel remodeling
|
GO:0060312 |
3 |
0.043
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.043
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.043
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.043
|
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.042
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.042
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.042
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.041
|
|
|
|
regulation of lens epithelial cell proliferation
|
GO:2001109 |
1 |
0.041
|
|
|
|
tripeptide transport
|
GO:0042939 |
1 |
0.041
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.041
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.040
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.040
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.040
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.039
|
|
|
|
positive regulation of vasculogenesis
|
GO:2001214 |
7 |
0.039
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.039
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.039
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.039
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.039
|
|
|
|
negative regulation of pathway restricted smad protein phosphorylation
|
GO:0060394 |
1 |
0.038
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.038
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.038
|
|
|
|
epithelial cell cell adhesion
|
GO:0090136 |
6 |
0.038
|
|
|
|
cellular phosphate ion homeostasis
|
GO:0030643 |
2 |
0.038
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.038
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.038
|
|
|
|
cardiogenic plate morphogenesis
|
GO:0003142 |
1 |
0.038
|
|
|
|
positive regulation of cytokine secretion involved in immune response
|
GO:0002741 |
2 |
0.038
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.037
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.037
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.037
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.037
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.037
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.037
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.037
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.037
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.036
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.036
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.036
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.036
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.036
|
|
|
|
equilibrioception
|
GO:0050957 |
3 |
0.036
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.036
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.035
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.035
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.035
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.035
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.035
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.034
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.034
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.034
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.034
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.034
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.034
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.034
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.034
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
26 |
0.034
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.034
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.034
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.034
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.034
|
|
|
|
positive regulation of g0 to g1 transition
|
GO:0070318 |
2 |
0.034
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.034
|
|
|
|
cardiac atrium development
|
GO:0003230 |
24 |
0.033
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.033
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.033
|
|
|
|
adherens junction assembly
|
GO:0034333 |
22 |
0.033
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.033
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.033
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.033
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.033
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.033
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.032
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.032
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.032
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.032
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.032
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.032
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.032
|
Mouse |
|
|
male gonad development
|
GO:0008584 |
88 |
0.031
|
|
|
|
germ line sex determination
|
GO:0018992 |
3 |
0.031
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.031
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.031
|
|
|
|
g0 to g1 transition
|
GO:0045023 |
3 |
0.031
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.031
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.031
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.031
|
|
|
|
ascending aorta morphogenesis
|
GO:0035910 |
3 |
0.031
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.031
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.031
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.031
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.031
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.031
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.031
|
|
|
|
endodermal digestive tract morphogenesis
|
GO:0061031 |
4 |
0.031
|
|
|
|
pigment biosynthetic process
|
GO:0046148 |
26 |
0.031
|
|
|
|
negative regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010642 |
7 |
0.030
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.030
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.030
|
|
|
|
cardiac atrium morphogenesis
|
GO:0003209 |
23 |
0.030
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.030
|
|
|
|
g protein coupled receptor signaling pathway involved in heart process
|
GO:0086103 |
4 |
0.030
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.030
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.030
|
|
|
|
regulation of cell proliferation involved in tissue homeostasis
|
GO:0060784 |
1 |
0.030
|
|
|
|
positive regulation of skeletal muscle tissue regeneration
|
GO:0043415 |
4 |
0.030
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.029
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.029
|
|
|
|
positive regulation of glutamate receptor signaling pathway
|
GO:1900451 |
3 |
0.029
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.029
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.029
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.029
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.029
|
|
|
|
lung smooth muscle development
|
GO:0061145 |
2 |
0.029
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.029
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.028
|
|
|
|
metanephric glomerular capillary formation
|
GO:0072277 |
3 |
0.028
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.028
|
|
|
|
phosphatidylinositol metabolic process
|
GO:0046488 |
45 |
0.028
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.028
|
|
|
|
angiogenesis involved in coronary vascular morphogenesis
|
GO:0060978 |
2 |
0.028
|
|
|
|
lymphoid progenitor cell differentiation
|
GO:0002320 |
17 |
0.028
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.028
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.028
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.028
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.028
|
Mouse |
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.027
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.027
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.027
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.027
|
|
|
|
detection of stimulus involved in sensory perception
|
GO:0050906 |
44 |
0.027
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.027
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.027
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
23 |
0.027
|
|
|
|
regulation of long term synaptic depression
|
GO:1900452 |
3 |
0.027
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.026
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.026
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.026
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.026
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.026
|
|
|
|
ruffle organization
|
GO:0031529 |
16 |
0.026
|
|
|
|
vascular endothelial growth factor signaling pathway
|
GO:0038084 |
10 |
0.026
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.026
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.025
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.025
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.025
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.025
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.025
|
|
|
|
metanephric glomerulus morphogenesis
|
GO:0072275 |
3 |
0.025
|
|
|
|
brain morphogenesis
|
GO:0048854 |
32 |
0.025
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.025
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.025
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.025
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.025
|
|
|
|
metanephric glomerulus vasculature morphogenesis
|
GO:0072276 |
3 |
0.025
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.024
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.024
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.024
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.024
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.024
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.024
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.024
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.024
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.024
|
|
|
|
t cell antigen processing and presentation
|
GO:0002457 |
2 |
0.024
|
|
|
|
response to heparin
|
GO:0071503 |
1 |
0.024
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.023
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014068 |
20 |
0.023
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.023
|
|
|
|
prostate gland morphogenetic growth
|
GO:0060737 |
4 |
0.023
|
|
|
|
chemical homeostasis within a tissue
|
GO:0048875 |
9 |
0.023
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.023
|
|
|
|
positive regulation of extracellular matrix assembly
|
GO:1901203 |
1 |
0.023
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.023
|
|
|
|
gall bladder development
|
GO:0061010 |
2 |
0.023
|
|
|
|
endothelial cell development
|
GO:0001885 |
20 |
0.023
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.023
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.023
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.023
|
|
|
|
positive regulation of endothelial cell proliferation
|
GO:0001938 |
17 |
0.023
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.023
|
|
|
|
calcium independent cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0016338 |
4 |
0.023
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.023
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.023
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.023
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.023
|
|
|
|
soft palate development
|
GO:0060023 |
2 |
0.023
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.023
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.023
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.023
|
|
|
|
cell migration involved in sprouting angiogenesis
|
GO:0002042 |
9 |
0.023
|
|
|
|
optic cup morphogenesis involved in camera type eye development
|
GO:0002072 |
7 |
0.023
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.022
|
|
|
|
positive regulation of hippo signaling
|
GO:0035332 |
1 |
0.022
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.022
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.022
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.022
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.022
|
|
|
|
closure of optic fissure
|
GO:0061386 |
2 |
0.022
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.022
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.022
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.022
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.022
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.022
|
|
|
|
inner cell mass cell differentiation
|
GO:0001826 |
7 |
0.022
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.022
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.022
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.022
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.022
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.022
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.022
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.022
|
|
|
|
melanocyte differentiation
|
GO:0030318 |
25 |
0.022
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.022
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.022
|
Mouse |
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.021
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.021
|
|
|
|
response to macrophage colony stimulating factor
|
GO:0036005 |
3 |
0.021
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.021
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.021
|
Mouse |
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.021
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.021
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.021
|
|
|
|
positive chemotaxis
|
GO:0050918 |
18 |
0.021
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.021
|
|
|
|
positive regulation of triglyceride lipase activity
|
GO:0061365 |
3 |
0.021
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.021
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.021
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.021
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.021
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.021
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.021
|
|
|
|
regulation of stem cell division
|
GO:2000035 |
4 |
0.021
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.021
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.020
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.020
|
|
|
|
bronchus cartilage development
|
GO:0060532 |
2 |
0.020
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.020
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.020
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.020
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.020
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.020
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.020
|
|
|
|
plasma membrane fusion
|
GO:0045026 |
9 |
0.020
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.020
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.020
|
|
|
|
venous blood vessel development
|
GO:0060841 |
13 |
0.020
|
|
|
|
kit signaling pathway
|
GO:0038109 |
3 |
0.020
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.020
|
|
|
|
pigment cell differentiation
|
GO:0050931 |
27 |
0.020
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.020
|
|
|
|
metanephric mesangial cell differentiation
|
GO:0072209 |
1 |
0.020
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.020
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.020
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.020
|
|
|
|
epithelial cell proliferation involved in prostate gland development
|
GO:0060767 |
11 |
0.019
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.019
|
|
|
|
positive regulation of lipoprotein lipase activity
|
GO:0051006 |
3 |
0.019
|
|
